Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,584.48
(
0.28%
)
US TECH 100
29,530.40
(
0.36%
)
Dow Jones
50,974.50
(
0.60%
)
Brent Oil
91.36
(
-0.89%
)
Bitcoin
73,438.33
(
-0.14%
)
News Focus
News Focus
Post# of 828130
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

longfellow95

Send PM Follow Ignore
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

longfellow95

Re: Know-Fear post# 214060

Monday, 02/11/2019 3:33:11 PM

Monday, February 11, 2019 3:33:11 PM

Post# of 828130
Yes, Prins's group did do a small DCVax/ICI combo study, but I can't recall if that was first in man or first in mouse.

If they do embark on the long-promised Nivo/DCVax combo in recurrent, at least they plan a DCVax only arm, which I suspect would do at least as well, without any toxicity that the other arm may experience.
Nivo has already failed abysmally in recurrent, with PFS of 1.5 months...
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News